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http://dx.doi.org/10.1016/j.ccr.2013.02.016SUMMARYUnderstanding themechanism underlying the regulation of the androgen receptor (AR), a central player in the
development of castration-resistant prostate cancer (CRPC), holds promise for overcoming the challenge of
treating CRPC. We demonstrate that the ubiquitin ligase Siah2 targets a select pool of NCOR1-bound, tran-
scriptionally-inactive AR for ubiquitin-dependent degradation, thereby promoting expression of select AR
target genes implicated in lipid metabolism, cell motility, and proliferation. Siah2 is required for prostate
cancer cell growth under androgen-deprivation conditions in vitro and in vivo, and Siah2 inhibition promotes
prostate cancer regression upon castration. Notably, Siah2 expression is markedly increased in human
CRPCs. Collectively, we find that selective regulation of AR transcriptional activity by the ubiquitin ligase
Siah2 is important for CRPC development.INTRODUCTION
In American men, prostate cancer (PCa) is the most commonly
diagnosed malignancy and the second leading cause of cancer
death. Signaling through the androgen receptor (AR), a member
of the nuclear receptor superfamily activated by steroids, plays
an essential role in the initiation and progression of PCa (Shen
and Abate-Shen, 2010). AR consists of an N-terminal domain,
a central DNA-binding domain (DBD), a hinge region, and
a C-terminal ligand-binding domain (LBD). AR transcriptional
activity is mediated via AF1 and AF2, two transactivation
domains located within the N-terminal and the LBD domains,
respectively. Upon ligand binding, AR translocates to the
nucleus and regulates gene expression through binding to
androgen-responsive elements (AREs) on the AR target genes.
Given the central role AR plays in the development of PCa,
androgen-deprivation therapy (ADT) is used as a first-line treat-Significance
Increased androgen receptor (AR) activity is central to the de
which is a major obstacle to the treatment of advanced/meta
the ubiquitin ligase Siah2 enhances the transcriptional activity
on select gene promoters/enhancers. Consequently, Siah2 p
to the growth of CRPC cells under androgen-deprivation co
a select subpopulation of AR target genes for the treatment o
approach.
332 Cancer Cell 23, 332–346, March 18, 2013 ª2013 Elsevier Inc.ment for metastatic PCa. Although such therapy achieves signif-
icant clinical response, patients with advanced prostate cancer
invariably relapse with a more aggressive form of PCa known
as castration-resistant PCa (CRPC). Studies on the patho-
genesis of CRPC have revealed that resumption of AR-depen-
dent transcriptional activity is a critical event in nearly all cases
(Waltering et al., 2012). Several mechanisms have been sug-
gested to mediate AR reactivation during CRPC progression,
including AR gene amplification or overexpression, AR muta-
tions conferring ligand promiscuity, expression of AR splice vari-
ants allowing androgen-independent activity, and intratumoral
androgen production.
Similar to other transcription factors, AR is subject to regula-
tion by the ubiquitin-proteasome pathway, and the E3 ubiquitin
ligases Mdm2 and CHIP have been implicated in the control of
AR stability and activity (Chymkowitch et al., 2011; Lin et al.,
2002). In humans, Siah1 and Siah2 comprise a two-membervelopment of castration-resistant prostate cancer (CRPC),
static prostate cancer with hormone therapy. We find that
of AR by degrading a transcriptionally-inactive pool of AR
romotes the expression of select AR target genes, leading
nditions. Our findings point to the importance of targeting
f CRPC and the possible consideration of Siah2 for such an
Figure 1. Siah2 Is Required for the Castration Sensitivity and
Expression of Select AR Targets in the TRAMP Atypical Hyperplasia
Model
(A) H&E staining of AH in the dorsal prostates of Siah2+/+;TRAMP or
Siah2/;TRAMP mice before and after castration.
(B) The scatter plot showing the average weight of dorsal prostates micro-
dissected from 5-month-old mice with or without 3-week castration (n = 10 for
each group). p = 0.17 for WT versus Siah KO,  castration; p < 0.005 for WT
versus Siah KO, + castration.
(C) Transcript levels of selected AR target genes in the prostates of
Siah2/;TRAMP mice after castration. RNA for qRT-PCR was isolated from
the dorsal prostates of 5-month-old mice with 3 week castration. p < 0.01
for NKX3.1, p < 0.005 for SPINK3, p < 0.05 for SBP, p > 0.1 for TMPRSS2,
probasin, or CK8. Data are mean ± SD.
See also Figure S1.
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Siah2 Controls AR Signaling in CRPCfamily of evolutionarily conserved RING finger E3 ubiquitin
ligases. The Siah proteins regulate ubiquitination-dependent
degradation of multiple substrates, including nuclear core-
pressor (NCOR1), b-catenin, TRAF2, a-ketoglutarate dehydro-
genase, and Sprouty 2, and thus influence an array of regulatory
functions such as the MAPK signaling, cell survival, and mito-
chondrial biogenesis (Kim et al., 2011; Nakayama et al., 2009).
Siah1 and Siah2 also enhance the availability and activity of
hypoxia-inducible factor (HIF-a) by mediating the ubiquitination
and degradation of HIF-a-negative regulators, including
PHD1/3, HIPK2, and FIH (Calzado et al., 2009; Fukuba et al.,
2008; Nakayama et al., 2004). Here, we identify Siah2 as an E3
ligase that targets a select pool of chromatin-bound ARs,
through which Siah2 controls the growth, survival, and tumori-
genic capacity of PCa cells, especially under conditions of
androgen deprivation.
RESULTS
Siah2 Deletion Increases the Castration Sensitivity
of TRAMP Mice
We previously reported that crossing Siah2/mice with TRAMP
(transgenic adenocarcinoma of the mouse prostate) mice abol-
ished the spontaneous formation of prostate NE tumors (Qi
et al., 2010). In the TRAMP model, prostate-specific expression
of SV40 T-antigen results in two types of lesions: NE carcinoma,
found in the ventral lobe, and atypical hyperplasia (AH; often
termed adenocarcinoma), which occurs in all lobes (Chiaverotti
et al., 2008). To further investigate the possible role of Siah2
in the development of prostate tumors, we subjected
Siah2/;TRAMP mice to castration. As expected, castration
caused shrinkage of AH in the dorsal prostate lobes of both
genotypes (Figure 1A). However, the weight of dorsal prostate
lobes was reduced approximately 10-fold in Siah2/;TRAMP
mice compared with 2.5-fold in the Siah2+/+;TRAMP mice
(Figure 1B). These results indicate that in TRAMP mice Siah2
deletion increased the sensitivity of AH to castration, implying
that Siah2 may be required for AR signaling when androgen
levels are low. Indeed, comparing expression of AR target genes
in the dorsal prostate from Siah2/;TRAMPmice with Siah2+/+;
TRAMP mice identified a greater reduction in transcript and
protein levels of some AR target genes (i.e.,NKX3.1 andSPINK3,
but not probasin and TMPRSS2; Figure 1C and Figure S1A
available online), pointing to the possibility that Siah2 regulates
the expression of a specific subset of AR target genes. The
reduction in lesions observed in Siah2-deficient mice is not likely
to be due to probasin-driven SV40 T-antigen expression, as the
level of probasin transcripts and SV40 T-antigen protein were
similar in Siah2+/+ and Siah2/;TRAMP tissues (Figures 1C
and S1B). In agreement, the dorsal prostates from both geno-
types expressed similar transcript levels of the luminal marker
CK8 (Figure 1C), suggesting that the reduced expression of AR
target genes was not due to a change in cellular differentiation.
Siah2 Is Required for Expression of a Subset of AR
Target Genes
To determine if Siah2 regulates AR activity in human PCa cells,
we used shRNA to inhibit Siah2 expression in androgen-depen-
dent LNCaP cells. Four of the 10 different Siah2 shRNAsCancer Cell 23, 332–346, March 18, 2013 ª2013 Elsevier Inc. 333
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Siah2 Controls AR Signaling in CRPCexamined elicited 70%–90% knockdown (Figure S2A). To deter-
mine if Siah2 regulated transcription of PSA, a well-established
AR target gene, LNCaP cells were cultured in medium supple-
mented with 5% charcoal stripped (CS)-fetal bovine serum
(FBS) for 2 days and then stimulated with the synthetic androgen
R1881 for 16 hr. Siah2 knockdown reduced PSA transcripts by
80%–90% in the absence of R1881 (Figure 2A) and by 50% in
the presence of a physiologic level of R1881 (0.5 nM), consistent
with changes reported upon knockdown of AR in LNCaP cells
(Bao et al., 2008). In the presence of high levels of R1881
(10 nM), the degree of reduced PSA transcript was limited to
20% (Figure 2A). These results indicate that Siah2 is required
for PSA transcription under conditions of both low and physio-
logic concentrations of androgen.
We next knocked down Siah2 in the androgen-independent
PCa cell line, CWR22Rv1 (Rv1), which expresses constitutively
active AR. Under androgen-deprivation conditions, Siah2
knockdown led to an 80% reduction in PSA transcript levels in
Rv1 cells in the presence or absence of androgen (R1881;
Figure 2B), confirming the importance of Siah2 for transcription
of AR target genes.
Because Siah2 plays an important role in regulating the cellular
response to hypoxia (Nakayama et al., 2004) and hypoxia has
been reported to activate AR activity, we examined transcription
of AR target genes under 1% O2. Surprisingly, the relative
change in PSA transcript levels upon Siah2 knockdown was
similar under normoxia and hypoxia (Figures 2B and 2C).
Notably, Siah2 knockdown reduced the transcript level of CA9,
a HIF target gene, only under hypoxia (Figures 2B and 2C). These
findings suggest that the effect of Siah2 on AR target gene
expression is independent of its established role in the hypoxia
response.
We next used qRT-PCR to compare the expression of repre-
sentative androgen-responsive genes (ARGs) in LNCaP or Rv1
cells subjected to inhibition of AR or Siah2 expression. Siah2
knockdown in LNCaP or Rv1 cells reduced the expression of
a subset of ARGs; transcripts of PSA, NKX3.1, PMEPA1, and
SLC45A3 were reduced by Siah2 knockdown while TMPRSS2
and FKBP5 transcripts were unaffected (Figures 2D and 2E). In
contrast, AR knockdown reduced the transcript levels of all
these representative ARGs (Figures 2D, S2B, and S2C). These
analyses confirmed that Siah2 modulates the expression of
a specific pool of AR target genes in both LNCaP and Rv1 cells.
To determine whether the effect of Siah2 on PSA transcripts is
AR dependent, we knocked down Siah2 in LNCaP or Rv1 cells
stably expressing AR shRNA. Although Siah2 knockdown
reduced the PSA transcript level in control cells, it failed to do
so in AR-knockdown cells (Figure 2F), suggesting that the
Siah2 effect on PSA is AR dependent.
To evaluate the global effect of Siah2 on transcription of ARGs,
we performed array-based gene expression analyses on Rv1
cells stably expressing Siah2 shRNA. Siah2 knockdown resulted
in downregulation of 981 genes (>1.5-fold; Table S1). Gene
network analysis, using the IPA software, was performed to iden-
tify possible enrichment of regulatory networks among the 981
genes. Notably, the AR-related genes were ranked among the
top three transcriptional networks that were responsive to
Siah2 inhibition (Figure 3A), with the other two being hypoxia-
and HNF4A-related. Changes in hypoxia-response genes are334 Cancer Cell 23, 332–346, March 18, 2013 ª2013 Elsevier Inc.consistent with the established role of Siah2 in control of
HIF-1a expression, stability, and activity (Calzado et al., 2009;
Fukuba et al., 2008; Nakayama et al., 2004). Further restricting
the analysis to genes that are primarily associated with prostate
cancer, we ranked the AR gene network as the primary one to be
altered upon Siah2 knockdown (Figure 3B). These analyses point
to AR as the major signaling pathway underlying Siah2-depen-
dent gene expression in the Rv1 cells. About 10% (98/981) of
Siah2-dependent genes were identified within the androgen-
induced gene cluster in an ARG data set (Figure 3C; Table S1).
Correspondingly, about 13% (98/759) of androgen-induced
genes in the ARG data set were enriched within the Siah2-
dependent expression cluster (Figure 3C). IPA analysis for
molecular and cellular functions revealed that the 98 Siah2-
dependent ARGs were associated with lipid metabolism, cell
movement, and cell proliferation (Figures 3D and 3E), whereas
the remaining 883 Siah2-dependent genes were associated
with DNA replication/repair, and cell morphology and prolifera-
tion (Figure 3F). Independent analysis using the GO pathway
software package confirmed lipid metabolism, steroid metabo-
lism, and cholesterol metabolism as the primary pathways
enriched in the 98 Siah2-dependent ARGs (Figure 3G; Table S2),
whereas the remaining 883 Siah2-dependent genes were asso-
ciated with oxidation, protein polymerization, and organic acid
metabolism (Figure 3H; Table S2). Together, these gene expres-
sion analyses substantiate the role of Siah2 in the regulation of
a subset of ARGs, while identifying distinct functional networks
that are associated with the Siah2-dependent ARGs.
To determine whether the Siah2-regulated ARGs are impor-
tant for the proliferation of PCa cells under the low androgen
condition, we performed a siRNA screen in which we have
targeted each of 98 Siah2-dependent ARGs. We identified 48
out of 98 siRNAs capable of inhibiting the proliferation of Rv1
cells grown in the CS-FBS medium by 10%–40% (Table S3).
Notably, the most pronounced inhibition was observed by
Siah2 siRNA. The siRNA screen also revealed that 8/16 Siah2-
dependent ARGs involved in the metabolisms of lipids, choles-
terol, and steroids (Figure 3E) were required for the proliferation
and survival of Rv1 cells (Table S3). Since SREBF1, a master
transcriptional regulator for lipid and cholesterol metabolism,
was found among the Siah2-dependent ARGs, we further
assessed the importance of SREBF1 for Siah2-dependent
effects on Rv1 cells maintained in the CS-FBS medium. Signifi-
cantly, inhibition of Rv1 cell proliferation upon Siah2 knockdown
could be partially rescued upon re-expression of SREBF1
(Figures S3A and S3B). These findings substantiate the impor-
tance of the Siah2-AR regulatory axis in control of lipid metabo-
lism for androgen-independent growth of Rv1 cells.
Comparison of the Siah2-dependent genes identified in our
study with the published profiling arrays on prostate cancers re-
vealed that 53 genes that were downregulated upon Siah2
knockdown in Rv1 cells were found to exhibit increased expres-
sion in the CRPC xenograft tumor model (Table S4) (Ettinger
et al., 2004), and 44 of those genes were upregulated in high-
grade prostate cancers (Table S5) (Taylor et al., 2010). Further-
more, analyses of profiling array data obtained from 35 CRPC
and 58 primary PCa samples (Grasso et al., 2012) confirmed
that 25% of Siah2-dependent ARGs identified in our current
study were upregulated in CRPCs and enriched for genes
Figure 2. Siah2 Is Required for the Expression of Select AR Targets in Human Prostate Cancer Cells
(A) Effect of Siah2 knockdown in LNCaP cells on the PSA transcript levels. Siah2 was knocked down in LNCaP cells using four different Siah2 shRNAs. LNCaP
transfectants were grown in medium containing 5% CS-FBS for 48 hr before treatment with 0.5 nM or 10 nM of synthetic androgen R1881 for 16 hr. The
differences in PSA transcript levels between Siah2-knockdown and pLKO.1-transfected control cells were statistically significant (p < 0.005) in the presence and
absence of androgen.
(B) Effect of Siah2 knockdown in Rv1 cells on the PSA transcript levels under normoxia or hypoxia. Rv1 cells transfectedwith Siah2 shRNAwere grown inmedium
containing 5% CS-FBS for 48 hr and then treated for 16 hr with or without hypoxia or 10 nM R1881. Hypoxia did not increase the PSA transcript level in either
pLKO.1 control or Siah2-knockdown cells (p > 0.1). N, normoxia; H, hypoxia.
(C) Effect of Siah2 knockdown in LNCaP cells on the PSA transcript levels under normoxia or hypoxia. The analysis was performed as for (B).
(D) qRT-PCR analysis of the indicated AR target genes in LNCaP cells transfected with shSiah2 or shAR vectors. Reduction in transcripts of PSA, NKX3.1,
PMEPA1, and SLC45A3 by shSiah2 or shAR was statistically significant. Transcripts of TMPRSS2 or FKBP5 were reduced by shAR (p < 0.01) but not by shSiah2
(p > 0.1).
(E) qRT-PCR analysis of the indicated AR target genes in Rv1 cells transfected with shSiah2 vector. Reduction in transcripts of PSA, NKX3.1, PMEPA1, and
SLC45A3 by shSiah2 was statistically significant (p < 0.01).
(F) qRT-PCR analysis of PSA transcripts in the indicated transfectants of LNCaP or Rv1 cells. The reduction of PSA transcript in the indicated knockdown cells
was statistically significant (p < 0.0005). Data are mean ± SD.
See also Figure S2.
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Figure 3. Bioinformatic Analyses of Siah2-
Dependent Genes in Rv1 Cells
(A) Top three transcription factors predicted to
underlie Siah2-dependent transcription by IPA. A
total of 981 genes downregulated upon Siah2
knockdown were subjected to IPA analysis against
canonical gene pathways.
(B) IPA analysis of transcription factors enriched
within the 981 genes, as described in (A), against
human prostate cancer cell data set.
(C) Venn diagram depicting overlap between
genes downregulated by Siah2 knockdown
and those induced by androgen signaling. The
androgen-induced ARGs in prostate cancer cells
were extracted from an ARG data set.
(D) The molecular and cellular functions of the 98
Siah2-dependent ARGs revealed by IPA analyses.
(E) Heatmap of the Siah2-dependet ARGs that
regulate biosynthesis and metabolism of lipid,
cholesterol, and steroids. Upregulated genes, red;
downregulated genes, green.
(F) The molecular and cellular functions of the 883
genes (Siah2-dependent but AR-independent) re-
vealed by IPA analyses.
(G) DAVID GOBP analyses of pathways enriched in
the 98 Siah2-dependent ARGs.
(H) DAVID GOBP analyses of pathways enriched
in the 833 genes (Siah2-dependent, but AR-
independent).
See also Figure S3 and Tables S1, S2, S3, S4, S5,
and S6.
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(Table S6). This observation substantiates the finding of metab-
olism and biosynthesis of lipids, cholesterol, and steroids as the
primary ARGs regulated by Siah2 (Figures 3D and 3E). Impor-
tantly, Siah2 expression was found to be upregulated in the
CRPC samples (Table S6), supporting a key role of Siah2 in
CRPC. These results further confirm Siah2-dependent expres-
sion of a select subset of genes that are implicated in the
progression and development of CRPC.
Siah2 Functions as an E3 Ubiquitin Ligase for AR
We next set to determine the mechanism underlying Siah2 effect
on AR. First, we determined whether Siah2 and AR interacted by
co-expressing AR with a wild-type (Siah2WT) or catalytically
inactive RING mutant form of Siah2 (Siah2RM), which forms
stable complexes with Siah2 substrates (Nakayama et al.,
2004). Analysis of AR immunoprecipitates showed that Siah2RM
or Siah2WT bound to AR protein (Figures 4A and S4A). Expres-
sion of Siah2WT, but not Siah2RM, reduced the levels of AR
overexpressed in 293T cells (Figure 4B) or PC3 cells (Figure S4B).
Overexpression of Siah2 in PCa cells also reduced the endoge-
nous levels of AR (Figure S4C). Similarly, reduction of AR levels336 Cancer Cell 23, 332–346, March 18, 2013 ª2013 Elsevier Inc.was observed following expression of
WT but not the RING mutant form of
Siah1a (S1aRM; Figure S4D). The effect
of Siah2 on AR levels was partially
blocked by treatment of 293T or PC3 cells
with the proteasome inhibitor MG132
(Figures S4E and S4F), suggesting thatSiah2 induces AR degradation via the ubiquitin-proteasome
pathway. To determine if AR was polyubiquitinated by Siah2,
we co-expressed Siah2, AR, and ubiquitin in 293T cells and
found that Siah2WT, but not Siah2RM, induced AR poly-
ubiquitination in the presence or absence of R1881 (Figure 4C).
Similarly, purified GST-Siah2 induced polyubiquitination of AR
in vitro (Figure S4G). Because polyubiquitination of AR can occur
on lysine residues other than lysine 48 (K48) (Xu et al., 2009), we
examined the topology of the AR ubiquitin chains by co-express-
ing AR, Siah2, and expression vectors for K48 or K63 mutant
ubiquitin (Figure 4D). Siah2 expression was found to enhance
polyubiquitination of AR in the presence of K63, but not K48,
mutant ubiquitin, suggesting that Siah2 promotes K48-linked
ubiquitination of AR. To determine whether Siah2 alters the
half-life of AR, we performed cycloheximide chase assays in
293T cells ectopically expressing AR, with or without Siah2.
Expression of Siah2 reduced the half-life of AR from 6 hr to
less than 2 hr (Figure S4H). These findings suggest that Siah2
regulates AR stability by targeting it for ubiquitination-dependent
degradation by the proteasomes.
We next mapped the AR domains required for Siah2
interaction by making domain-deletion mutants of AR and
Cancer Cell
Siah2 Controls AR Signaling in CRPCco-expressing them with Siah2 in 293T cells. Western blot anal-
yses indicated that AR mutants containing the AF2 domain were
degraded by Siah2, whereas AF2-deficient mutants were resis-
tant to Siah2-induced degradation (Figures S4I and S4J), sug-
gesting that Siah2 interacts with the AF2 domain of AR. Indeed,
GST-Siah2 was able to pull down the AF2, but not the AF1,
domain of AR (Figure 4E). Siah2 consists of an N-terminal
domain, a central RING domain/zinc finger domain, and
a C-terminal substrate-binding domain (SBD) (Figure S4K). To
map the Siah2 domain required for AR interaction, we generated
truncation mutants of Siah2 and co-expressed them with AR in
293T cells. Immunoblotting revealed that both the Siah2 SBD
and central RING domain/zinc finger domains interacted with
AR (Figure 4F).
Because Siah2 interacts with the AR LBD, we tested whether
the presence of androgen affects the AR–Siah2 interaction and
whether Siah2 affects androgen–AR binding. The interaction
between ectopic AR and Siah2 was unaffected by R1881
(Figure S4L), suggesting that ligand binding does not affect
the AR–Siah2 interaction. Further, knockdown of Siah2 in Rv1
cells did not influence the affinity of [3H]-labeled R1881 for the
endogenous AR or its dissociation rate (Figure S4M). These
observations indicate that ligand binding does not affect the
AR–Siah2 interaction, nor does Siah2 affect the androgen–AR
interaction.
AR Contains Two Major Siah2-Binding Sites
To identify the regions of the AR LBD that interacted with Siah2,
we mutated AR with a series of single amino acid mutations that
had been previously characterized in human PCa samples. The
mutated ARs were individually co-expressed with Siah2RM in
293T cells, and the binding between AR mutants and Siah2RM
was assessed by co-immunoprecipitation experiments.
AR constructs with the mutations R726L, Q798E, and F754L,
all containing solvent-accessible side chains, showed the great-
est reduction in Siah2 binding. R726L is clustered in the AF2 site
with three other mutations (V715M, H874Y, and V730M) that
cause moderate inhibition of Siah2 binding (Figures 4G–4I).
Two additional mutations (L701H and T877A) in the AR ligand-
binding pocket proximal to the AF2 site had moderate effects
on Siah2 binding to AR.
The two remaining mutations that strongly reduced Siah2–AR
binding (Q798E and F754L) are located in proximity in a hydro-
phobic cleft on the opposite side of the AR hinge region
(Figure 4I). Interestingly, a mutation at V757, which lies just under
this cleft, does not significantly decrease the Siah2–AR associa-
tion, which points to its specific recognition of this cleft. In
summary, the mutational analysis identified two solvent-acces-
sible surfaces on AR LBD that are required for the interaction
with Siah2.
To determine whether the Siah2–AR interaction is essential for
AR transcriptional activity, we monitored the PSA promoter-
driven luciferase activity in AR null PC3 cells transfected with
AR mutants. Although knockdown of Siah2 reduced luciferase
activity induced by WT AR or an AR mutant (G683A) capable of
associating with Siah2 under both low and normal androgen
conditions, it had limited effect on luciferase activity induced
by AR mutants (R726L or Q798E) with markedly (70%) reduced
Siah2-binding abilities (Figure 4J). Consistently, AR mutantsR726L or Q798E showed impaired Siah2-dependent ubiquitina-
tion, compared with WT AR or G683A mutant AR (Figure S4N).
These observations indicate that AR mutations that prevent
Siah2-binding also prevent Siah2-mediated ubiquitination of
AR and regulation of AR transcriptional activity, and further
support the importance of the Siah2-AR association in the
control of selected AR target genes, illustrated here by the
PSA promoter.
Siah2 Is Required for Degradation of NCOR1-Bound AR
on AREs of Selective AR Target Genes
To further understand Siah2 regulation of AR activity, we as-
sessed whether knockdown of Siah2 affected levels of total,
nuclear, or chromatin-bound AR in PCa cells. Significantly,
Siah2 had no effect on any of these AR pools (Figures S5A–
S5F). Overexpression of Siah2 in 293T cells did not affect the
AR intermolecular N-terminal and C-terminal interaction
(Figure S5G), which is known to regulate AR transcriptional
activity. Because Siah2 knockdown reduced transcripts of
specific AR target genes (Figure 2), we determined if Siah2
modulates AR binding to target gene promoters/enhancers.
For this, we used PSA, NKX3.1, and PMEPA1 as representative
Siah2-regulated AR target genes and TMPRSS2 as a Siah2-
independent AR target gene. The results of ChIP assays
confirmed androgen-dependent association of Siah2 with the
AREs of PSA, NKX3.1, and PMEPA1 in LNCaP cells, but not
with ARE of TMPRSS2 (Figure 5A). Binding of Siah2 to the
AREs of PSA, NKX3.1, and PMEPA1 was reduced by knock-
down of AR or Siah2 (Figure 5A), suggesting that Siah2 was re-
cruited to these chromatin regions by AR. Similar results were
observed for the Siah2 ChIP assays performed in Rv1 cells
(Figure 5B). Because NCOR1 is a known AR corepressor and
a Siah2 substrate (Frasor et al., 2005; Zhang et al., 1998), we per-
formed ChIP assays to determine whether Siah2 knockdown
affected the binding of AR and NCOR1 to the AR target genes.
Siah2 knockdown in LNCaP and Rv1 cells increased the level
of AR and NCOR1 on the AREs of PSA, NKX3.1, and PMEPA1
(Figures 5C, 5D, S5H, and S5I). As expected, binding of AR
and NCOR1 to the ARE of TMPRSS2 was unaffected by Siah2
knockdown (Figures 5D and S5J). Knockdown of Siah2 had no
effect on the global level of AR (Figure S5A) or NCOR1
(Figure S5K). These results suggest that Siah2 is required for
the degradation of AR and NCOR1, at selective AR target genes.
To further evaluate this hypothesis, we performed additional
ChIP assays with 29 randomly selected AR targets (16 Siah2-
dependent and 13 Siah2-independent, based on our global
gene expression analysis; Figure 3). ChIP was performed on
Rv1 cells (pLKO.1 control versus Siah2 knockdown cells) using
antibodies to Siah2, NCOR1, and AR, and the precipitated chro-
matins were subjected to qRT-PCR analyses for AREs of the 29
AR targets. Some of the AREs have been reported in the litera-
ture; for the remainder, we consulted published ChIP-seq or
ChIP-on-chip studies and then validated AR binding to the
AREs by ChIP-PCR analyses. These experiments revealed that
Siah2 knockdown increased the levels of AR and NCOR1 bound
to 11 of the 16 Siah2-dependent AR targets (68.75%) (Figures
S5L and S5M), whereas none of the 13 Siah2-independent
AR targets showed such change (data not shown). This
analysis satisfied statistical power analyses, which indicatedCancer Cell 23, 332–346, March 18, 2013 ª2013 Elsevier Inc. 337
Figure 4. Siah2 Interacts with and Ubiquitinates AR for Proteasome-Dependent Degradation
(A) 293T cells were transfected with Flag-AR and GFP-Siah2RM for 24 hr before immunoprecipitation with anti-Flag M2 beads. Bound proteins were eluted and
analyzed by western blotting with Flag or GFP antibodies.
(B) 293T cells were transfected with Flag-tagged AR and Siah2 (WT or RM) for 24 hr. Whole cell lysates were analyzed by western blotting with the antibodies of
Flag, tubulin, and actin.
(C) 293T cells were transfected with Flag-AR, HA-Ub, and GFP-Siah2 (WT or RM) for 24 hr in the presence or absence of 10 nM R1881. Cells were treated with
20 mMMG132 for 5 hr and then Flag-ARwas immunoprecipitated withM2 beads under denaturing conditions. The immunoprecipitates were analyzed bywestern
blotting with HA or Flag antibody. The input of GFP-Siah2 was immunoblotted with GFP antibody.
(D) 293T cells were transfectedwith Flag-AR, HA-Ub (WT, K48mutant, K63mutant, and K48/K63 double mutant), and GFP-Siah2. The analysis was performed as
described for (C).
(E) Flag-AF2 or-AF1was in vitro translated (35S labeling), purified, and incubated with GST-Siah2. Proteins bound to GST-Siah2 were analyzed by SDS-PAGE and
phosphoimaging.
(legend continued on next page)
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Notably, Siah2 binding was demonstrated for nine of the 11
Siah2-dependent AR targets that exhibited increased AR/
NCOR1 binding, compared with only one of the five Siah2-
dependent AR targets that did not show increased AR/NCOR1
binding (Figure S5N). The association between Siah2 binding
to AREs in control cells and the increased NCOR1/AR binding
to these AREs upon Siah2 knockdown was statistically signifi-
cant (p < 0.05, Fisher’s exact test). Importantly, none of the
Siah2-independent AR targets exhibited Siah2 binding (data
not shown).
Collectively, the above data substantiate our conclusion that
Siah2 targets the degradation of NCOR1-bound AR on a select
group of AR target genes. Consistent with this, ChIP assays
revealed that Siah2 knockdown reduced the level of ubiquiti-
nated proteins on AREs of PSA, NKX3.1, and PMEPA1, but not
TMPRSS2 (Figure 5E). Notably, knockdown of NCOR1 attenu-
ated the recruitment of Siah2 (Figures 5B and S5O) and the
accumulation of AR on AREs of PSA, NKX3.1, and PMEPA1
was further reduced upon Siah2 knockdown (Figures 5C, S5H,
and S5I). Moreover, coprecipitation experiments showed a
markedly higher association of Siah2 with the AR/NCOR1
complex than with AR alone (Figure 5F). These results suggest
that the NCOR1-bound AR recruits Siah2 more efficiently.
Indeed, knockdown of NCOR1 in Rv1 cells increased the tran-
scripts of PSA, NKX3.1, and PMEPA1 in both control and
Siah2-knockdown cells, but the effect was more pronounced
in Siah2-knockdown cells (Figure 5G). Together, these results
suggest that Siah2 may promote the AR transcriptional output
via degradation of the transcriptionally-inactive AR (marked by
NCOR1 binding) on the AREs of selective AR targets.
To investigate whether Siah2-mediated degradation of
NCOR1-bound AR could affect binding of a co-activator to AR,
we performed ChIP-reChIP assays that enable detection of
multiple protein-protein interactions on specific chromatin
regions. ChIP of Siah2 followed by reChIP of AR, NCOR1, and
co-activator p300 revealed that Siah2 interacted with AR and
NCOR1 but not with p300 on the PSA promoter (Figure 5H).
Consistent with this, ChIP-reChIP assays revealed that NCOR1
and co-activator p300 are present in distinct AR complexes on
the promoter of PSA gene (Figure 5I), and knockdown of
NCOR1 increased the amount of p300 and acetylated histone
H3 on the PSA promoter (Figures 5J and 5K), suggesting that
competitive binding between p300 and NCOR1 to the ARmodu-
lates PSA promoter activity, consistent with findings from(F) Identification of the AR-interacting domains of Siah2. Myc-AR was cotransfect
middle part) in 293T cells. Siah2 fragments were immunoprecipitated with M2 bea
AR antibody.
(G) 293T cells were cotransfected with GFP-Siah2RM and Flag-AR mutants as in
samples were analyzed by western blotting using GFP or Flag antibody. The inte
Siah2RM is shown at the bottom panel.
(H and I) Structural location of AR LBDmutants inWT AR. Ribbon presentation of th
key helix H1 (H). The side chains of residues that were mutated are drawn as s
depending on their effect on Siah2 interaction. A 90 rotation of the model is sho
(J) PC3 cells (pLKO.1 or shSiah2) were cotransfected with a PSA promoterGauss
ARs indicated. Cells were grown in medium containing 5%CS-FBS for 48 hr and
to theCypridina luciferase activity (n = 3). Data are mean ± SD. Siah2 knockdown
the absence or presence of R1881 (p < 0.05).
See also Figure S4.a previous report (Yoon and Wong, 2006). Interestingly, knock-
down of Siah2 decreased the amount of p300 and acetylated
histone H3 on the PSA promoter (Figures 5J and 5K), opposite
to what was seen upon NCOR1 knockdown. Given that Siah2
knockdown increased the amount of NCOR1-bound AR on the
PSA promoter (Figure 5C), these results suggest that Siah2-
mediated degradation of NCOR1-bound AR (transcriptionally
inactive) on PSA promoter allows the subsequent recruitment
of p300-bound AR (transcriptionally active), leading to an
increase in the transcription of PSA gene.
Knockdown of the E3 ubiquitin ligase Mdm2 in MEFs express-
ing ectopic AR has also been reported to disrupt AR turnover at
the PSA promoter (Chymkowitch et al., 2011). To compare the
effects of Siah2 and Mdm2 on AR transcriptional activity, we
knocked down Mdm2 in Rv1 cells and examined transcripts of
representative ARGs. The expression of some ARGs was regu-
lated by both Siah2 and Mdm2 (e.g., PSA, SLC45A3), while
others were regulated only by Siah2 (e.g., NKX3.1, PMEPA1) or
Mdm2 (e.g., TMPRSS2), and some were unaffected by either
protein (e.g., FKBP5) (Figures 2E and S5P). Knockdown of
Mdm2 had little effect on the total level of AR (Figure S5Q), as
had been observed with Siah2 knockdown. Additional regulatory
layers (i.e., posttranslational modifications) are expected to exist
in the control of AR by distinct ubiquitin ligases.
Modulation of AR Transcriptional Activity by Siah2
Is Required for Growth and Motility of Prostate
Cancer Cells
We next evaluated the physiologic significance of Siah2 regula-
tion of AR activity. Knockdown of Siah2 or AR significantly
reduced proliferation of Rv1 and LNCaP cells (Figures 6A and
6B). However, knockdown of Siah2 in AR-knockdown cells did
not further reduce cell proliferation (Figure 6B), suggesting that
the Siah2 effect on cell proliferation may be AR dependent. Simi-
larly, knockdownof Siah2 or AR inRv1 orC4-2 cells (a castration-
resistant subline of LNCaP) abolished anchorage-independent
growth, as demonstrated by an inability to form colonies in soft
agar (Figures 6C and 6D). In contrast, knockdown of Siah2 in
AR-negative PC3 or DU145 cells (Figure S6A) had no apparent
effect on cell growth (Figure 6A) or anchorage-independent
growth (Figure S6B). Knockdown of Siah2 or AR in Rv1 cells
reduced sphere formation in three-dimensional Matrigel to the
levels seenwith control Rv1 cells cultured under androgen-depri-
vation conditions (Figures 6E and S6C). Further, Siah2 or AR
knockdown inhibited Rv1 and LNCaP cell motility in transwelled with Flag-tagged Siah2 fragments (N, N-terminal part; C, C-terminal part; M,
ds and coprecipitated Myc-AR was analyzed by western blotting using Flag or
dicated. After 24 hr, immunoprecipitation was performed using M2 beads and
nsity ratios between GFP-S2RM and Flag-ARs are shown. The input of GFP-
e LBDwith the AF2 site helices highlighted in blue and labeled in addition to the
ticks, labeled, and colored green (strong), red (moderate), or blue (no effect)
wn to highlight the location of V757, F754, and Q798 (I).
ia luciferase construct, a control Cypridina luciferase construct, and the mutant
treated with 1 nM of R1881 for 16 hr.Gaussia luciferase activity was normalized
reduced PSA promoter activity in cells expressing WT AR or G683mutant AR in
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Figure 5. Siah2 Promotes the AR Transcriptional Activity by Targeting the NCOR1-Bound AR
(A) LNCaP cells stably transfected with control, AR shRNA, or Siah2 shRNAwere grown in the absence or presence of 1 nM of R1881 for 12 hr, treated with 20 mM
MG132 for 5 hr, and collected for ChIP assays using an anti-Siah2 antibody. Purified chromatin was analyzed by qPCR for the ARE regions of PSA, NKX3.1,
PMEPA1, and TMPRSS2. Siah2 was enriched on AREs of PSA, NKX3.1, and PMEPA1 in the presence of R1881 (p < 0.05), but not on the ARE of TMPRSS2 gene
(p = 0.62).
(B) Rv1 cells stably transfected with control, AR shRNA, or NCOR1 shRNA were grown in the normal growth medium, treated with 20 mM MG132 for 5 hr, and
collected for the ChIP assays using anti-Siah2 antibody as described in (A). AR or NCOR1 knockdown affected Siah2 presence on the AREs of PSA, NKX3.1, and
PMEPA1 (p < 0.05) and TMPRSS2 (p > 0.1).
(C) Effect of Siah2 knockdown in LNCaP cells on the association of AR and NCOR1with the PSA promoter. ChIP assays were performed on LNCaP cells (pLKO.1
or shSiah2) using anti-AR or anti-NCOR1 antibodies and purified chromatins were analyzed by qPCR for the ARE region of PSA gene. Relative change in AR
(p < 0.05) or NCOR1 (p < 0.0005) in the presence of R1881 or upon knockdown of Siah2, or NCOR1 (p > 0.1) is shown.
(legend continued on next page)
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Siah2 Controls AR Signaling in CRPCassays, and this effect was amplified under androgen-depriva-
tion conditions (Figures 6F, 6G, and S6D). In contrast, knock-
down of Siah2 in AR-negative PC3 cells showed no effect on
cellmotility (FigureS6E).Collectively, thesedata strongly support
a key role forSiah2 in thegrowth andmotility of PCacells,which is
mediated at least partially through regulation of AR activity.
Siah2 Is Important for Growth of Castration-Resistant
Prostate Tumors
Having established that Siah2 influences the growth and
motility of AR-positive PCa cells in vitro, we next addressed
its role in vivo. To establish CRPC, we used an orthotopic pros-
tate tumor model in which the androgen-independent C4-2 cell
line was injected into the dorsal prostate lobes of nude mice.
We established C4-2 cells with stable knockdown of Siah2
and verified that they were similar to LNCaP Siah2-knockdown
cells in both transcript levels of ARGs and in vitro growth char-
acteristics (Figures S7A–S7C). Tumors derived from the Siah2-
knockdown C4-2 cells were about half the size of those derived
from control C4-2 cells (Figure 7A). Castration had no effect on
tumor size of control cells, consistent with the fact that growth
of C4-2 cells is androgen independent. Interestingly, the size of
Siah2-knockdown tumors was reduced in response to castra-
tion (Figure 7A), suggesting that Siah2 contributed to the
castration resistance of human PCa cells. qRT-PCR analyses
revealed lower transcript levels of selective ARGs in the
Siah2-knockdown C4-2 tumors, which were further lowered
after castration (Figure 7B). In agreement, knockdown of AR
reduced the C4-2 xenograft tumor size and PSA level in the
castrated mice (Snoek et al., 2009). These findings suggest
that Siah2-dependent regulation of AR activity may contribute
to the castration resistance of C4-2 tumors.
Prostatic stromal cells from transgenic mice with a conditional
knockout of the tumor growth factor-b (TGF-b) receptor type II in
fibroblasts (Tgfbr2fspKO and Tgfbr2ColTKO) conferred resistance
to castration in the prostate cancer models (Bhowmick et al.,
2004). To further test the role of Siah2 in castration resistance,
we knocked down Siah2 expression in a mouse prostate cancer(D) Effect of Siah2 knockdown in Rv1 cells on the association of AR andNCOR1wi
cells (pLKO.1 control or shSiah2) using anti-AR or anti-NCOR1 antibodies and p
PMEPA1 and TMPRSS2. Level of AR (p < 0.05) and NCOR1 (p < 0.05) on the AR
TMPRSS2 (p > 0.1).
(E) Effect of Siah2 knockdown in Rv1 cells on the association of ubiquitinated prote
on Rv1 cells (pLKO.1 control or shSiah2) using anti-ubiquitin antibody and analyze
regions of PSA, NKX3.1, and PMEPA1 (p < 0.05), compared with the ARE on TM
(F) 293T cells were transfected with Flag-AR or Flag-AR/myc-NCOR1, which we
expressing GFP-Siah2RM. After three washes, the proteins were eluted and ana
(G) qRT-PCR of the indicated genes was performed on Rv1 cells (pLKO.1 or shSia
NKX3.1, and PMEPA1 in pLKO.1 or Siah2 KD cells by the NCOR1 siRNA (p < 0.
(H) LNCaP cells were treated with 1 nM of R1881 for 12 hr, 20 mMMG132 for 5 hr, a
the first IP were used for the second round of IP (reChIP) using antibodies indicat
region of PSA promoter. Relative enrichment by AR or NCOR1 antibody (p < 0.0
(I) LNCaP cells were treated with 1 nMof R1881 for 12 hr, and collected for the first
followed by the second round of IP (reChIP) using the antibodies indicated, and a
antibody is shown (p < 0.05).
(J) LNCaP cells subjected to NCOR1 or Siah2 KD were treated with 1 nM of R188
qPCR of the ARE region of PSA promoter. p300 enrichment upon NCOR1 or Sia
(K) ChIP assays using acetylated histone H3 antibodywere performed on LNCaP c
antibody on PSA promoter upon NCOR1 or Siah2 knockdown (p < 0.05). Data a
See also Figure S5.cell line MPC3, knocked out for Pten and Trp53. Knockdown of
Siah2 in MPC3 cells also reduced the transcription of selective
AR targets (Figure S7D), characteristic of the Pten prostate
cancer model (Mulholland et al., 2011). Tissue-recombination
experiments combining WT or Tgfbr2-KO prostate stromal cells
with MPC3 cells (control or Siah2 knockdown) were orthotopi-
cally grafted. The tumors grew diffusely in the mouse prostate
and did not form a distinctive mass. The growth of MPC3 cells
in vivo was evaluated by phosphorylated-histone H3, Ki67, and
TUNEL staining. Knockdown of Siah2 in MPC3 cells recombined
with WT prostate stromal cells led to reduced phospho-histone
H3, Ki67, and TUNEL staining in castrated mice (Figures 7C,
7D, S7E, and S7F), indicative of Siah20s role in the castration-
resistant growth of MPC3 cells. Notably, co-culture of the
Siah2-knockdown MPC3 cells with Tgfbr2-KO prostate stromal
cells diminished the requirement of Siah2 for the proliferation
of MPC3 cells in the castrated mice (Figures 7D and S7F).
Tgfbr2-KO prostate stromal cells are known to promote the
castration resistance of prostate epithelia via paracrine secretion
of growth factors such as Wnt3a, interleukin-6 (IL-6), IL-1b, and
human growth factor (HGF) (Bhowmick et al., 2004; Kiskowski
et al., 2011), which can bypass the requirement for androgen
signaling and thus Siah2 for the progression of MPC3 cells in
the castrated mice. Together, these observations substantiate
the role of Siah2 in the progression of CRPC.
Siah2Expression IsUpregulated inCastration-Resistant
Human Prostate Cancer
To verify the relevance of our findings to human PCa, we
measured Siah2 expression in human castration-resistant pros-
tate tumor samples. Siah2was detected immunohistochemically
in a PCa tissue microarray (TMA) containing representative
samples of different Gleason stage tumors and castration-resis-
tant tumors (Figures 7E–7G; Table S7). Siah2 showed a nuclear
expression pattern in both the benign and the cancer cells.
However, in the benign tissues, Siah2 was mostly present in
basal cells, not luminal cells (Figure 7E). Compared to benign
tissues, Siah2 expression was upregulated in PCa tissues, andth the AREs of PSA, NKX3.1 and PMEPA1. ChIP assayswere performed onRv1
urified chromatins were analyzed by qPCR for ARE regions of PSA, NKX3.1,
Es of PSA, NKX3.1, and PMEPA1 upon Siah2 KD, compared with the ARE of
ins with the AREs of PSA, NKX3.1, and PMEPA1. ChIP assays were performed
d as described in (D). Level of ubiquitinated proteins upon Siah2 KD on the ARE
PRSS2 gene (p = 0.55).
re isolated by purification on M2 beads and then incubated with 293T lysates
lyzed by western blotting using the antibodies of Flag, Myc or GFP.
h2) transfected with NCOR1 siRNA. Shown is the change in transcripts of PSA,
05).
nd collected for the first round of IP (ChIP) using Siah2 antibody. The eluates of
ed. The purified chromatins by the reChIP were analyzed by qPCR for the ARE
5), or p300 antibody (p = 0.76) is shown.
round of IP (ChIP) using p300 (left columns) or NCOR1 (right columns) antibody
nalyzed by qPCR for the ARE region of PSA gene. Enrichment of reChIP by AR
1 for 12 hr, collected for the ChIP assays using p300 antibody, and analyzed by
h2 KD (p < 0.05) is shown.
ells as described in J. Shown is the relative enrichment of acetylated histone H3
re mean ± SD.
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Figure 6. The Siah2 Effect on AR for the Proliferation and Motility of PCa Cells
(A) Effect of Siah2 knockdown on the growth of human PCa cells. LNCaP, Rv1, PC3, or DU145 cells were stably transfected with Siah2 shRNA or control
pLKO.1 vector. Equal numbers of cells (1 3 104) were seeded in 12-well plates in medium containing 5% FBS (+androgen) or 5% CS-FBS (androgen) and
cells were counted after 5 days (n = 3). Change in cell growth upon Siah2 KD in LNCaP or Rv1 cells was maintained in the presence or absence of androgen
(p < 0.05).
(B) Siah2 or AR was stably knocked down individually or in combination in LNCaP or Rv1 cells. Equal numbers of cells (53 104) were grown in six-well plates and
cells were counted after 5 days (n = 3). Change in growth of Rv1 (p < 0.01) or LNCaP (p < 0.005) is shown.
(C) Knockdown of Siah2 or AR in Rv1 cells on the colony formation in soft agar assays. Cells (pKLO.1 control, shSiah2, or shAR) were maintained in soft agar for
3 weeks before staining with p-iodonitrotetrazolium violet. The number of colonies per field was quantified (p < 0.0001).
(D) Siah2 or AR KD effect on colony formation of C4-2 cells (p < 0.00005), was carried out as detailed in (C).
(legend continued on next page)
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Siah2 Controls AR Signaling in CRPCinterestingly, Siah2 upregulation was seen across Gleason
stages within this cohort (Figure 7F). Significantly, levels of
Siah2 expression were closely associated with ADT and devel-
opment of CRPC, reflected in reduction of Siah2 levels after
ADT and elevation of Siah2 levels in CRPC (Figure 7G). Interest-
ingly the level of Siah2 protein in human CRPC resembles the
changes seen in Siah2 transcripts in the human CRPC xenograft
model; while the level of Siah2 transcripts was reduced upon
castration, it increased during development of CRPC (Fig-
ure S7G). Notably, whereas Siah2 level is associated with clinical
recurrence upon ADT, it is not associated with recurrence after
prostatectomy (Figure 7H). Consistent with the upregulation of
Siah2 in CRPCs, the endogenous Siah2 level is higher in the
two androgen-independent PCa cell lines C4-2 and Rv1 than in
the androgen-dependent LNCaP cells or the AR null PC3 cells
(Figure S7H). Immunohistochemical staining of CLGN and
ACPP (Siah2-dependent AR targets) in the human PCa tumor
microarray revealed their elevated expression (30% increase,
p < 0.05) in CRPCs compared with the naive PCa samples
(Figure S7I, data not shown). The latter substantiate the signifi-
cance of Siah2-dependent AR targets in CRPCs.
DISCUSSION
Understanding the mechanisms underlying AR activity is impor-
tant for the development of effective therapeutic modalities to
treat CRPC. Here, we identified an undisclosed facet of AR regu-
lation and demonstrated its consequences for the growth of
castration-resistant prostate tumors. Our studies reveal that
the E3 ubiquitin ligase Siah2 regulates a subset of AR, bound
to the corepressor NCOR1, resulting in removal of the transcrip-
tionally-inactive AR from chromatin. The specificity of Siah2 for
the NCOR1-bound AR is achieved through Siah2 interaction
with two accessible surfaces on AR, concomitant with its inter-
action with the AR/NCOR1 complex. Siah2-dependent removal
of NCOR1-bound AR allows the binding of p300-bound AR to
the AREs of PSA gene. Collectively, our findings suggest amodel
whereby Siah2 recognition and degradation of a specific inactive
AR pool enables recycling of AR, whereby inactive AR-NCOR1
is replaced with active AR-p300, thereby sustaining consti-
tutive AR-dependent transcription from selected promoters/
enhancers.
The finding that Siah2 ubiquitin ligase controls a subset of AR
is consistent with the concept that some transcription factors are
removed from target promoters via the ubiquitin-proteasome
pathway to allow binding of new factors and continued transcrip-
tion (Muratani and Tansey, 2003). A similar mechanism has been
proposed for regulation of PSA by Mdm2 (Chymkowitch et al.,
2011), and interestingly, both Mdm2 and Siah2 reportedly regu-
late HIPK2 stability (Calzado et al., 2009; Rinaldo et al., 2007).
Thus, the interplay between these two ligases may dictate the
duration, level, and/or specificity of transcriptional output. It is(E and F) Rv1 cells (pLKO.1, shSiah2, and shAR) were grown in the three-dimensio
1 week (E). The number of spheres (>25 mm in diameter) grown in the presence
shSiah2, and shAR) were subjected to transwell assays in the presence (5% FBS
(G) Migration of LNCaP cells upon KD of Siah2 or AR in the presence (p < 0.0005
described in (F). Data are mean ± SD.
See also Figure S6.equally plausible that Siah2 and Mdm2 play distinct roles in AR
turnover for different pools of AR target genes, or under varying
physiologic conditions. We favor the latter possibility, which is
supported by the observation that Siah2 and Mdm2 regulate
different AR targets (Figures 2E and S5P). Although we provide
evidence that Siah2 contributes to AR turnover on the AREs of
selective AR targets, we cannot exclude the possibility that it
regulates AR activity through additional mechanisms, such as
promoting recruitment of co-activators or degrading/displacing
corepressors.
How do the Siah2-regulated ARGs contribute to CRPC? Our
gene expression profiling studies point to Siah2-dependent
regulation of AR target genes associated with sterol and lipid
metabolism. These findings were confirmed by qPCR analyses
in PCa cells and identification of this gene cluster in independent
data sets reported for PCa and CRPC. Of those, a master regu-
lator of lipid metabolism, SREBF1, a Siah2-dependent ARG,
plays an important role in the proliferation of Rv1 cells under
low androgen condition (Figure S3B) and is upregulated in
CRPC (Table S6). SREBF1 induces the expression of enzymes
involved in fatty acid and cholesterol synthesis, thereby
providing CRPC cells with fatty acids for energy and membrane
synthesis, and cholesterol for intratumoral de novo synthesis of
androgens (Ettinger et al., 2004; Locke et al., 2008). Among the
enzymes underlying the intratumoral androgen metabolism are
AKR1C2, AKR1C3, and UGT2B15, which are upregulated in
CRPC (Cai et al., 2011; Stanbrough et al., 2006), consistent
with their downregulation in the Siah2-knockdown Rv1 cells.
We previously reported that Siah2-dependent regulation of
HIF was important to the neuroendocrine differentiation (NED)
of PCa cells under chronic hypoxic conditions (Qi et al., 2010).
Here, we show that Siah2-dependent regulation of AR activity
is equivalent under normoxia and hypoxia. Notably, NED foci
of prostate cancer express little or no AR protein (Huang et al.,
2006), suggesting that the effect of Siah2 on AR activity is not
applicable for NED foci, where the Siah2 contribution is medi-
ated through its concerted regulation of HIF-1a and FoxA2
(Qi et al., 2010). Siah2 thus elicit distinct effects in different
PCa cell populations: it enhances HIF activity in NED foci
and promotes AR activity in PCa cells surrounding these foci.
Importantly, through independent mechanisms in each of these
cell populations, Siah2 contributes to the castration resistance of
PCa. Thus, the role played by Siah2 in controlling AR signaling,
castration resistance, and NED of PCa makes it a promising
target for PCa therapy, either alone or in combination with other
therapeutic approaches.EXPERIMENTAL PROCEDURES
Prostate Tumor Samples
A total of 194 prostate cancer specimens were obtained from the Vancouver
Prostate Tissue Bank under approval by Clinical Research Ethics Boardnal Matrigel in the presence (5%FBS) or absence (5%CS-FBS) of androgen for
(p < 0.05) or absence (p < 0.005) of androgen is shown (F). Rv1 cells (pLKO.1,
; p < 0.0005) or absence (5% CS-FBS; p < 0.05) of androgen for 24 hr.
) or absence (p < 0.001) of androgen, monitored using the transwell assays as
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Siah2 Controls AR Signaling in CRPC(# H09-01628; informed consent was obtained from all subjects). All the
specimens were from radical prostatectomy except the 12 CRPC
samples, which were obtained from transurethral resections of prostate.
The hematoxylin and eosin (H&E) slides were reviewed and the desired
areas were marked. Three TMAs were manually constructed (Beecher
Instruments, MD, USA) by punching duplicate cores of 1 mm from each
sample.
Animal Studies
Animals were housed in the Sanford-Burnham Medical Research Institute
(SBMRI) animal facility, or Cedars-Sinai Medical Center (CSMC). All experi-
ments were approved by the Institutional Animal Care and Use Committee
(IACUC # 55545 and 56155 at SBMRI and IACUC # 3679 at CSMC) and
were conducted following the Institute’s animal policy in accordance with
National Institutes of Health (NIH) guidelines.
Cell Lines
LNCaP, C4-2, PC3, DU145, and CWR22 Rv1 cells were maintained in RPMI
1640 medium supplemented with 10% FBS and antibiotics.
Generation of Siah2–/–;TRAMP Mice
Siah2+/ mice (129/SvJ background) were crossed with TRAMP transgenic
mice (C57BL/6 background) to obtain Siah2+/;TRAMP mice. Female
Siah2+/;TRAMP mice were crossed with male Siah2+/ mice to generate
mice of the genotypes Siah2+/+;TRAMP, Siah2+/;TRAMP, and Siah2/;
TRAMP (Qi et al., 2010).
Antibodies and Reagents
Antibodies to AR, p300, ubiquitin, GFP, myc, Mdm2, tubulin, actin (Santa
Cruz), NCOR1, Histone H3, GFP, NKX3.1, Ki67, SV40 T-antigen (Abcam), acet-
ylated histone H3 (anti-AcH3-K9, Upstate Biotechnology), Siah2 (Novus Bio-
logicals), ACPP (Pierce), CLGN (Abgent), phospho-histone H3, SPINK3 (cell
signaling), and Flag (Sigma) were used according to the manufacturers’
recommendations.
Statistical Analysis
The data were analyzed by Student’s t test, one-way ANOVA, or Fisher’s exact
test. A p value < 0.05 was considered statistically significant.ACCESSION NUMBER
The GEO accession number for the microarray data reported in this paper
is GSE38851.Figure 7. Siah2 Promotes the Growth of CRPC Orthotopic Tumors, an
(A) Orthotopic tumor size of C4-2 cells expressing Siah2 shRNA with or without ca
of nude mice and 3 weeks later one group of mice was castrated for 4 weeks. T
pLKO.1,  castration versus shSiah2,  castration; p < 0.01 for shSiah2,  cas
pLKO.1, + castration.
(B) qRT-PCR analysis of the indicated genes on RNA samples extracted from the o
CLGN upon Siah2 KD with or without castration (p < 0.05).
(C) The phospho-histone and TUNEL staining on theMPC3 tumor tissues collected
were recombined with WT or Tgfr2 KO prostate stromal cells for an orthotopic inje
were collected and subjected to IHC analyses.
(D) Quantification of phospho-histone and TUNEL staining shown in (C).
(E) Representative images of Siah2 IHC staining on the PCa TMA. BPH, benign p
(F) Quantification of Siah2 IHC staining on the BPH and PCa samples of different G
except Gleason3 versus Gleason5 (lower number of cases in Gleason5 group).
(G) Quantification of Siah2 IHC staining on the PCa samples without or with ADT
CRPC compared with all other groups and for untreated PCa compared with all
(H) Quantification of Siah2 staining on the PCa samples after prostatectomy or
between recurrent and nonrecurrent cases in samples after ADT (p < 0.0001), an
tatectomy (p < 0.1). Data are mean ± SD.
See also Figure S7 and Table S7.SUPPLEMENTAL INFORMATION
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